Loss of attachment to an extracellular matrix substrate arrests the growth of untransformed cells in the G1 phase. This anchorage-dependent cell cycle arrest is linked to increased expression of the p21 Cip1 (p21) and p27 Kip1 (p27) cyclin-dependent kinase inhibitors. The result is a loss of cdk2-associated kinase activity, especially that of cyclin E-cdk2. The levels of p21 and p27 are also upregulated in unattached transformed cells, but cyclin E-cdk2 activity remains high, and the cells are able to grow in an anchorage-independent manner. Increased expression of cyclin E and cdk2 appears to be partially responsible for the maintenance of cyclin E-cdk2 activity in transformed cells. To explore further the regulation of cyclin E-cdk2 in transformed cells, we have analysed the subcellular distribution of cyclin-cdk complexes and their inhibitors in normal human ®broblasts, their transformed counterparts, and in various human tumor cell lines. In substrateattached normal ®broblasts, cyclin E and cdk2 were exclusively in the nuclear fraction, associated with one another. When normal ®broblasts were detached and held in suspension, cyclin E-cdk2 complexes remained nuclear, but were now found associated with the p21 and p27 cdk inhibitors and lacked histone H1 phosphorylating activity. In contrast, the transformed ®broblasts and tumor cells, which are anchorage-independent, had more than half of their cyclin E, cdk2, p21 and p27 in the cytoplasmic fraction, both in attached and suspended cultures. The cytoplasmic p21 and p27 were bound to cyclin E-cdk2, as well as to complexes containing cyclin A and cyclin D. The nuclear cyclin E-cdk2 complexes from the transformed cells grown in suspension contained only low levels of p21 and p27 and had histone H1 kinase activity. Thus, at least three mechanisms contribute to keeping cyclin Ecdk2 complexes active in suspended anchorage-independent cells: cyclin E and cdk2 are upregulated, as reported previously, cdk inhibitors are sequestered away from the nucleus by cytoplasmic cyclin-cdk complexes, and the binding of the inhibitors to nuclear cyclin E-cdk2 complexes is impaired.
Introduction
Most normal cells require attachment to a substratum to survive and to grow. This phenomenon is referred to as anchorage dependence, and it is mediated by attachment of cells to extracellular matrix proteins through integrins (Ruoslahti and Reed, 1995) . Fibroblasts detached from extracellular matrix stop growing, whereas epithelial and endothelial cells undergo apoptosis (Meredith et al., 1993; Frisch and Francis, 1994; Re et al., 1994) . Anchorage dependence is likely to be important for the maintenance of tissue architecture; it prevents cells from detaching and moving into inappropriate places in tissues.
Detachment of cells from matrix results in a loss of integrin signaling, that results in changes in cell cycle regulation (Koyama et al., 1996; Wary et al., 1996; Assoian and Zhu, 1996;  for review see Assoian, 1997) . In human ®broblasts, detachment causes upregulation of the cell cycle inhibitors p21 and p27 and the inhibitors arrest the cell cycle at the G1/S transition by inactivating the cyclin E-cdk2 complex . An increase in the levels of either or both of the inhibitors, accompanied by inactivation of cyclin Dcdk4 or cyclin E/A-cdk2 complexes, has also been observed in other cell types such as NRK, NIH3T3, and Rat1 ®broblasts (Zhu et al., 1996; Schulze et al., 1996) . Similar cell cycle inhibition is also seen in smooth muscle cells growth arrested upon loss of anchorage, or as a result of growing on an inhibitory extracellular matrix (Koyama et al., 1996) , or disruption of the actin cytoskeleton in normal human ®broblasts . Contact inhibition of growth in cells that have grown con¯uent and attach to one another is also mediated by p27 (Polyak et al., 1994; Hengst and Reed, 1996; St Croix et al., 1996; Coats et al., 1996) . Thus, regulating cdk inhibitors appears to be a general pathway used by cells to respond to changes in attachment (for review see Ruoslahti and O È brink, 1996) .
Malignant cells are generally independent of anchorage and this is thought to be of fundamental importance for invasiveness and metastasis (Folkman, 1978) . Tumor cells circumvent the anchorage requirement of normal cells by bypassing the signaling pathways triggered by matrix attachment. For example, Src-transformation results in constitutive phosphorylation (activation) of a number of signaling proteins that are normally activated upon integrinmediated cell attachment (Frisch and Francis, 1994; Richardson and Parsons, 1996) and v-Abl transformation results in enhanced activation of cyclin E-cdk2 complexes and in increased c-myc transcription (Zou et al., 1997) . Malignantly transformed cells also show abnormalities in the pathway from cell attachment to regulation of the cyclin/cdk complexes. Thus, for example, transformed ®broblasts have active cyclin Ecdk2 complexes regardless of whether they are attached and despite the elevation in cdk inhibitor expression that occurs upon detachment from matrix . One reason for the lack of proper cyclin E-cdk2 regulation in these cells appears to be an elevated expression of the cyclin E and cdk2 proteins (Fang et al., 1996) .
We show here that various types of malignantly transformed cells maintain anchorage-independent cyclin E-cdk2 activity by excluding the majority of p21 and p27 from the nucleus, and by compromising the association of nuclearly localized inhibitors with cyclin E-cdk2 complexes.
Results

Expression of p21 and p27 cyclin-cdk inhibitors in suspended anchorage-independent cells
We have previously shown that p21 and p27 expression is elevated in the transformed cell line HUT12 when they are cultured in suspension . To determine whether this happens in other anchorage-independent cells, we analysed p21 and p27 expression levels in several anchorageindependent cell lines. The results are shown in Figure 1 and summarized in Table 1 . Complex patterns of inhibitor expression were found: Some of the cells expressed less p21 or both p21 and p27 than anchorage-dependent ®broblasts, but nevertheless responded to loss of adhesion with increased expression of the inhibitors; up to fourfold increases in p21 and p27 were seen (e.g. HUT12 and 172 in Figure 1a ). p57 expression did not change in suspended cells. Despite the elevated p21 and p27 levels, the cyclin E-cdk2 complexes remained active in all these transformed cell lines in suspension culture ( Figure 1b and Table 1 ).
Cytoplasmic displacement of p21 and p27
To determine the reasons for the retention of cyclin Ecdk2 activity in the suspended anchorage-independent cell lines, we studied the subcellular localization of p21 and p27 by cell fractionation. Whereas both inhibitors were exclusively nuclear in suspended normal fibroblasts ( Figure 2a , top lanes 1 ± 4), a considerable fraction, sometimes a majority of both proteins, was in the cytoplasmic fraction in suspended anchorageindependent cells (Figure 2a) .
The completeness of the subcellular fractionation was evaluated by studying the distribution of known nuclear and cytoplasmic marker proteins in one of the cell lines, HUT12. a-tubulin, a commonly used cytoplasmic marker, was found exclusively in the cytoplasmic fraction, whereas histone H3 was exclusively nuclear ( Figure 2b ). Two nuclear proteins, the faster migrating and active form of cdk7 and cyclin H were found in the nuclear fraction of the HUT12 cells (Figure 2a) , as well as of normal ®broblasts (Table 2) . Moreover, a slower migrating form of p27 was present in the cytoplasmic, but not the nuclear fraction of , 1996) . C is normal rabbit serum control MG-63 cells (Figure 2a ). These results clearly validate the subcellular fractionation procedure.
To con®rm the subcellular localizations of p21 and p27 inferred from the cell fractionation, we carried out immuno¯uorescence staining of ®xed cells (Figure 3) . The staining for p21 and p27 was entirely nuclear in the MRC-5 normal ®broblasts, whereas substantial cytoplasmic staining was seen in the anchorageindependent cell lines HUT12, KRIB and 172 (data not shown). As expected, histone H3 was exclusively nuclear in HUT12 cells, whereas a-tubulin was cytoplasmic.
Cyclin E and cdk2 in anchorage-independent cells
Cyclin E and cdk2 levels are higher in anchorageindependent HUT12 cells than in anchorage-dependent ®broblasts . An increase in cyclin E-cdk2 complex levels and potentially compensate for the increase in p21 and p27 that takes place in suspension cultures, allowing HUT12 cell growth to be anchorage-independent. To determine whether the increase in cyclin E-cdk2 complexes plays a role in the altered distribution of p21 and p27 in transformed cells, we compared the subcellular localization of cyclin E and cdk2 in HUT12 cells and normal ®broblasts. Immunoblotting of nuclear and cytoplasmic fractions showed that cyclin E and cdk2 were up to 40% more abundant in the cytoplasmic than nuclear fraction of HUT12 cells in late G1 (Figure 4a , lanes 1 ± 4). Similar results were obtained with the 172, KRIB, MG-63 and 293 cells (Table 2 ). In contrast, both proteins were exclusively nuclear in normal KD ®broblasts ( Figure  4a , lanes 5 ± 8).
Even though a considerable fraction of the cyclin E and cdk2 protein of the HUT12 cells was in the cytoplasmic fraction, the nuclear fraction of these cells still contained about sevenfold more cyclin E and cdk2 than that of the normal ®broblasts (data not shown). Immunoprecipitation with anti-cdk2 followed by blotting with anti-cyclin E revealed the presence of cyclin E-cdk2 complexes in the cytoplasmic fraction of the HUT12 cells ( Figure 4b ). However, not all the cytoplasmic cdk2 was cyclin-associated, because a signi®cant fraction remained in the cyclin E-depleted supernatant (data not shown). The presence of noncyclin associated cdk2 was also suggested by the observation that less than half of the cytoplasmic cdk2 was in the Thr160-phosphorylated form, which is characteristic of cyclin-associated cdk2.
The localization of cyclin E in both the nucleus and cytoplasm of the anchorage-independent cells was con®rmed by immunostaining with anti-cyclin E antibodies. Nuclear and cytoplasmic staining was obtained with polyclonal and monoclonal anti-cyclin E antibodies in both the HUT12 and KRIB cells. The HUT12 staining with the polyclonal antibodies is shown in Figure 5 . In agreement with the cell fractionation experiments, the MRC-5 normal fibroblasts showed exclusively nuclear cyclin E staining. For the KD cells, cdk2-associated p21 and p27 is shown after immunoprecipitating cdk2 and probing the immunocomplexes for the inhibitors. The cytoplasmic lysates were devoid of p21 and p27, con®rming exclusively nuclear localization (lanes 3 and 4) of these inhibitors in normal ®broblasts (data not shown). (b) Controls for the subcellular fractionation. The distribution of the nuclear markers cyclin H, the fast-migrating, active form of cdk7 and histone H3, and the cytoplasmic marker a-tubulin was analysed by immunoblotting. Equal amounts (50 mg) of cytoplasmic and nuclear fractions from attached and suspended HUT12 cells were tested with the appropriate antibodies Association of nuclear and cytoplasmic cyclin E-cdk2 with p21 and p27
We next studied the association of p21 and p27 with the cyclin E-cdk2 complexes in the subcellular compartments. Cyclin E and cdk2 were immunoprecipitated from nuclear and cytoplasmic fractions of ®ve anchorage independent cell lines, grown as either attached or suspended cultures, and assayed for associated inhibitors by immunoblotting. In each case, the immunoprecipitated protein was recovered in the precipitate, with only occasional trace amounts in the supernatant (data not shown). The results of the inhibitor analysis are shown for three representative cell lines in Figure 6a . All of the cell lines had p21 and p27 associated with cyclin E-cdk2 complexes in the cytoplasmic fraction, more so in suspension than in attached cultures. In general, the nuclear cyclin E-cdk2 complexes from the anchorage-independent cells reproducibly contained very little or no associated p21 or p27 (Figure 6 ), even though some of the lines had signi®cant nuclear levels of these inhibitors ( Figure  2a) . KRIB ( Figure 6 ) and MG-63 (data not shown) cells showed no detectable inhibitors associated with their nuclear cyclin E-cdk2 complexes, even when twice as much KRIB nuclear extract was used. More p21 and p27 was bound to cdk2 than to cyclin E in 293 ( Figure 6 ) and 172 (data not shown) cells, indicating that cdk2-complexes other than cyclin E-cdk2 had bound some of the inhibitors. These results were reproducible in several independent experiments. Moreover, the nuclear cyclin E-cdk-2 complexes from attached and suspended KRIB cells were active in phosphorylating histone H1 (Figure 6b ).
Cytoplasmic p21 and p27 are partially associated with cyclin A and D
We also looked for possible association of p21 and p27 with cyclin A, cyclin D, and cdk4. Each of these proteins was present in the cytoplasm of the various anchorage-independent cells, as determined by immunoblotting ( Figure 4a and Table 2 ) and immunouorescence ( Figure 5 ). A detailed analysis was performed in the HUT12 cells (Figure 7) . We prepared immunoprecipitates from cytoplasmic and nuclear fractions of HUT12 cells with antibodies against p21 and p27 and immunoblotted them with anti-cyclin A, anti cyclin D and anti-cdk4 (Figure 7a) . Alternatively, we immunoblotted cyclin and cdk4 immunoprecipitates with anti-p21 and anti-p27 (Figure 7b) . In each case, we analysed primary and secondary immunoprecipitates as well as the remaining supernatants to account for all of the protein that was being analysed.
MRC-5 HUT12 KRIB HUT12
Figure 3 Localization of p21 and p27 by immuno¯uorescence staining. Asynchronously growing HUT12 cells and contactinhibited normal MRC-5 ®broblasts were ®xed and stained for expression of the cdk inhibitors (upper panels for each cell line). The localization of the nuclear marker histone H3 and the cytoplasmic marker a-tubulin in the HUT12 cells is also shown (lower right). Histone 3 is seen in two cells. The nuclei in each microscopic ®eld were visualized with Hoechst-33258 (unlabeled panels)
The results showed that a fraction of p21 and p27 is associated with cyclins A and D in the HUT12 cytoplasm (Figure 7a ). The amounts were comparable to those associated with cyclin E. Cdk4 immunoprecipitates also contained some of the inhibitors, presumably because of the association of cdk4 with cyclin D (La Baer et al., 1997). Most of the nuclear cyclin D was bound to the inhibitors, because it was not detected in the supernatants depleted of p21 and p27 (Figure 7a, lanes 7 and 15) . Some cytoplasmic, but essentially no nuclear cdk4, was bound to the inhibitors (Figure 7a , lanes 5 and 13; Figure 7b , lane 5).
Whereas the cytoplasmic cyclin E and A complexes contained abundant p21 and p27 (Figure 7a , lanes 2 and 10; Figure 7b , lane 2), only a minor fraction of cyclins E and A was found in the inhibitor immunoprecipitates from the nucleus (Figure 7a p21 can also interact with PCNA, and this interaction is believed to contribute to a p21-mediated cell cycle arrest (reviewed in Kelman, 1997) . We found PCNA to be overexpressed in HUT12 cells compared to normal ®broblasts (data not shown). In addition to con®rming its expected localization in the nucleus, we also found PCNA in the cytoplasmic fractions of HUT12 (Figure 7a ) and of the other anchorageindependent cells (Table 2) . Some of the cytoplasmic PCNA was bound to p21 (Figure 7a , lane 10). In contrast, nuclear PCNA was essentially free of p21 (Figure 7a, lane 13) .
One of the anchorage-independent cell lines we studied (293), expresses adenovirus (Ad) E1A. E1A has been shown to bind p27 (and to p21; R Poon and M Harter, personal communication) and can prevent the association of p27 with cyclin-cdk2 complexes when overexpressed in transfected cells (Mal et al., 1996) . Immunoblotting of p27 immunoprecipitates for E1A showed that E1A is associated with p27 in both the nuclear and the cytoplasmic fractions of the 293 cells, with more p27-associated E1A in the cytoplasmic fraction (Figure 8 ). Since p27 was also found associated with cyclin E-cdk2 in 293 cells (Figure 6 ), we deduce that a fraction of the p27 population is not bound to E1A, but E1A may nonetheless contribute to the neutralization of the cyclin inhibitors in these cells.
Discussion
We show here that several transformed and tumor cell lines, unlike normal ®broblasts, have a major portion of their cyclin E and cdk2 located in the cytoplasm. The cytoplasmic cyclin E-cdk2 and other cytoplasmic cyclin-cdk complexes are bound to cdk inhibitors p21 and p27, providing one mechanism for maintaining anchorage-independent activity of nuclear cyclin Ecdk2 complexes in tumor cells.
Changes in the expression and activities of cyclincdk complexes have been implicated in anchorage independence, one of the fundamental properties of transformed and tumor cells. Some anchorage-dependent cell lines downregulate their cyclin D expression when they lose anchorage to a substrate (Zhu et al., 1996) , while in normal ®broblasts loss of adhesion results in inactivation of the cyclin E-cdk2 complex by cdk inhibitors . Transformed and tumorigenic cell lines are independent of anchorage, and this trait correlates with sustained activity of cyclin E-cdk2 in cells taken into suspension this study) . Like normal cells, anchorageindependent transformed cells upregulate the p21 and p27 cdk inhibitors upon loss of anchorage , and this would be expected to cause cell cycle arrest. Increased expression of cyclin E and cdk2 (Keyomarsi et al., 1994 (Keyomarsi et al., , 1995 Dutta et al., 1995; Kitahara et al., 1995; Miyajima et al., 1996; WeinstatSaslow et al., 1995) appears to be one of the mechanisms transformed cells use to neutralize the cdk inhibitors.
The neutralization of the cdk inhibitors by cyclincdk complexes in anchorage-independent cells appears to take place in the cytoplasm. Cytoplasmic expression of cyclin E, cdk2 and other cyclins correlated with the anchorage-independent, transformed phenotype in our study. We detected no cytoplasmic cyclins or cdk2 in two anchorage-dependent cell lines, whereas ®ve transformed and tumorigenic cell lines all expressed a major portion of these proteins in the cytoplasm. Dierences in the fractionation of proteins in normal and transformed cells into nuclear and cytoplasmic fractions cannot account for the cyclin-cdk distribution Complexing of cytoplasmic and nuclear cyclins E and A with cdk2. Cytoplasmic and nuclear fractions (50 mg) from attached and suspended HUT12 cells were immunoprecipitated with an antibody against cdk2, and cyclins E and A were detected in the precipitates by immunoblotting with speci®c antibodies. The lanes marked with C are controls with the anti-cdk2 antibody and protein A Sepharose, but no cell fraction. The identity of cdk2, cyclin E and A was con®rmed by comparing the mobility to that of the same proteins in whole cell lysates (data not shown) dierence, because nuclear and cytoplasmic markers distributed in the expected fractions in each cell type. Moreover, immunostaining of the cyclin and cdk proteins in situ con®rmed the cytoplasmic localization in transformed cells. Thus, our results appear to be an accurate re¯ection of the presence of substantial quantities of cyclin and cdk proteins in the cytoplasm of transformed and tumor cell lines. To our knowledge this is the ®rst report on cytoplasmic localization of a major fraction of cyclins and cdk's.
Cyclins E and A lack a nuclear localization signal (NLS) that would allow their entry into the nucleus on their own (Robbins et al., 1991) but association with a cdk can eect nuclear translocation (Maridor et al., 1993) . We ®nd that, despite having formed a complex with cdk2, cyclin E and A remain partially in the cytoplasm. The mechanism whereby the cyclin-cdk complexes are retained in the cytoplasm remains to be elucidated. However, it is noteworthy that cyclin E is toxic when overexpressed in yeast (Sewing et al., 1994) and uncouples DNA replication from the cell cycle in ®broblasts (Mumberg et al., 1996) . Thus, the overexpression of cyclin E that is strongly correlated with malignant transformation (this study; Keyomarsi et al., 1994; Dutta et al., 1995; Weinstat-Saslow et al., 1995; Dou et al., 1996) , may be possible only when most of the overexpressed cyclin E remains cytoplasmic, as it does in the transformed and tumor cells we have studied.
Both, p21 and p27 have an NLS that could facilitate nuclear entry of associated cyclin E-cdk2 complexes as was recently demonstrated for cyclin D-cdk4 complexes (LaBaer et al., 1997) . Such transfer is obviously impaired in our tumor cell lines, because we detect inhibitor-containing cyclin E-cdk2 complexes in the cytoplasm. Cyclin E-cdk2(-inhibitor) complexes in transformed cells could be associated with a protein that causes cytoplasmic retention was recently shown for JIP-1 associated JNK (Dickens et al., 1997) . A cytoplasmic retention signal can be dominant over the NLS as is the case with cyclin B-cdc2 complexes (Pines and Hunter, 1994) .
The binding to the cytoplasmic cyclin-cdk complexes is likely to sequester the inhibitors away from the critical nuclear cyclin-cdk complexes. Thus, we propose that the cytoplasmic cyclins may neutralize the inhibitors in transformed and tumorigenic cells, leaving the nuclear cyclin-cdk complexes active and capable of promoting rapid and inappropriate cell cycling. Cytoplasmic cyclin D-cdk4/6-p15 inhibitor complexes have been described in a dierent role; in Mv1Lu cells that inducibly express p15 cytoplasmic p15 prevents cyclin D-cdk4/6 from binding p27, thus leaving p27 free to enter the nucleus and block cell cycle progression by inactivating other cyclin-cdk complexes (ReynisdoÂ ttir and MassagueÂ , 1997) .
The overexpressed and cytoplasmic cyclin-cdk complexes may not be the only factor securing cyclin E-cdk2 activity in unattached transformed cells. We ®nd that although some fraction of p21 and p27 is nuclear in such cells, it is mostly not associated with cyclin E-cdk2. Other binders of the cdk inhibitors such as the adenovirus E1A protein (Mal et al., 1996) , present in one of our cell lines, human papillomavirus E7 protein and possibly cellular counterparts of such viral proteins may contribute to the impairment of cdk inhibitor function. c-Myc-induced sequestration of p27 in a form that is unable to bind and inhibit cyclin E-cdk2 (Vlach et al., 1996) is another possible mechanism for neutralizing the inhibitors. That multiple mechanisms exist to maintain anchorage-independent activity of cyclin E-cdk2 in transformed and tumorigenic cells is likely to re¯ect the importance of cyclin E for anchorage independent cell growth.
Materials and methods
Cell culture and cell fractionation
Normal human ®broblasts KD (Kakunaga, 1978) , FS (foreskin), IMR-90, and MRC-5, embryonic mouse ®broblasts (EMFI), and rat ®broblasts (Rat-1) were cultured in 14 cm dishes in Dulbecco's minimum essential medium (a-MEM) supplemented with 10% fetal calf serum (FCS) and antibiotics. Cells were used at passage 20 or below except EMFI, which were used at or below passage 5. HUT12 (a chemically transformed KD cell line; Kakunaga, 1978) , 172 MDAH (a spontaneously immortalized ®broblastic cell line from a Li-Fraumeni patient; Medcalf et al., 1996) , KRIB (a Ki-Ras overexpressing osteosarcoma cell line; Samid and Mandler, 1989) , MG-63 and SK-UT-1 (human osteosarcoma cell lines), and 293 cells (Ad5 E1A-expressing human embryonic kidney cell line) were cultured as described above for the normal ®broblasts. All cell lines were from the American Type Culture Collection if not indicated otherwise. Fibroblasts and HUT12 cells were cultured in monolayer or suspension cultures and were synchronized by serum starvation . Serum-starved cells were scraped from the tissue culture dishes, suspended either in 10% FCS/a-MEM before reattachment or were kept in 1% Methocel (Rheinwald and Green, 1974) in 10% FCS/a-MEM for the suspended cultures for 7 h (G1) and 14 ± 18 h (G1/S). The suspension culture was then sealed in a 50 ml Corning tube and incubated in a rolling incubator at 378C. Cells were lysed either in RIPA buer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS, 50 mM NaF, 0.5 mM Na 3 VO 4 , 10 mg/ml leupeptin, 4 mg/ml pepstatin, 0.1 U/ml aprotinin) or in 0.1% NP-40 buer (50 mM Tris-HCl, pH 7.4, 5 mM NaF, 250 mM NaCl, 5 mM EDTA, 0.1% NP-40, 15 mg/ml benzamidine, 10 mg/ml trypsin inhibitor, 10 mg/ml leupeptin, 4 mg/ml pepstatin, 0.1 U/ml aprotinin), or were subjected to subcellular fractionation according to a modi®ed protocol from Dignam et al. (1983) . In the fractionation, the cells were left to swell on ice for 30 ± 45 min in hypotonic buer A (1.5 mM MgCl 2 , 10 mM HEPES pH 7.9, 10 mM KCl, 0.5 mM DTT, 10 mg/ml leupeptin, 4 mg/ml pepstatin, 0.1 U/ ml aprotinin, 15 mg/ml benzamidine, 10 mg/ml trypsin inhibitor) before the cell membranes were disrupted by shearing the cells three times for 10 s in a blender (OMNI-1000, Waterbury, CT). Disruption of the cell membrane was con®rmed under the microscope. The cytoplasm was separated from the nuclear fraction by centrifugation for 10 min at 10 000 r.p.m. in the cold and was frozen at liquid nitrogen temperature. Proteins from the nuclear pellet were recovered either by three rounds of extraction with buer C (0.5% NP-40, 10 mM Na-phosphate, pH 7.4, 120 mM NaCl, 0.1 mM PMSF, 10 mg/ml leupeptin, 4 mg/ml pepstatin, 0.1 U/ ml aprotinin, 15 mg/ml benzamidine, 10 mg/ml trypsin inhibitor) or by suspending the pellet in RIPA buer followed by shearing the DNA 10 times through a 23 gauge needle. After centrifugation, the insoluble pellet was discarded. Protein contents were determined with the BioRad DC system. Protein analysis showed that 35% of the cellular protein recovered was in the nuclear fraction and 65% was in the cytoplasmic fraction. 
